Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT
Philip Hykin, A. Toby Prevost, Sobha Sivaprasad, Joana C. Vasconcelos, Caroline Murphy, Joanna Kelly, Jayashree Ramu, Abualbishr Alshreef, Laura Flight, Rebekah Pennington, Barry Hounsome, Ellen Lever, Andrew Metry, Edith Poku, Yit Yang, Simon P. Harding, Andrew Lotery, Usha Chakravarthy, John Brazier
Research output: Contribution to journal › Article › peer-review
10Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT'. Together they form a unique fingerprint.